DifGenBeyond's analysis on DifGen2026-07-27 — FDA clears DifGen Pharmaceuticals to start clinical development of single‑injection breast cancer drug DFGN‑101Recent news mentioning DifGen2026-07-27 — DifGen Pharmaceuticals Receives FDA Clearance to Begin Clinical Development for a Single Injection treatment for Advanced Breast Cancer DFGN-101Appears alongsideFDABrowse the full archive →